Related Experiment Video
Updated: Jun 16, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?
Kathleen A Hazlewood1, Sara D Brouse, William D Pitcher
1Texas Tech University Health Sciences Center, Dallas, TX, USA.
Vancomycin dosing strategies impact patient outcomes. Aggressive dosing may increase nephrotoxicity risk, especially in patients with risk factors, while inadequate dosing can lead to treatment failures and resistance.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Vancomycin-associated nephrotoxicity rates were historically low (0-5%) but have become a concern with evolving treatment practices.
- Treatment failures with standard vancomycin doses for methicillin-resistant Staphylococcus aureus (MRSA) infections have prompted higher, supra-therapeutic dosing.
- Clinical practice guidelines recommend higher vancomycin trough concentrations (10-20 microg/mL), potentially increasing nephrotoxicity risk.
Purpose of the Study:
- To evaluate the association between vancomycin dosing strategies and nephrotoxicity.
- To examine the impact of aggressive vancomycin dosing on kidney injury in patients with MRSA infections.
- To highlight the importance of appropriate vancomycin dosing to balance efficacy and safety.
Main Methods:
- Review of clinical trials and studies comparing vancomycin dosing regimens.
- Analysis of factors confounding vancomycin-associated nephrotoxicity, including concomitant nephrotoxins and patient comorbidities.
- Assessment of the relationship between vancomycin trough concentrations and adverse renal events.
Main Results:
- Increased nephrotoxicity rates are linked to aggressive vancomycin dosing, particularly in patients with pre-existing risk factors.
- Vancomycin's nephrotoxicity risk appears minimal in patients without specific risk factors for kidney injury.
- Inadequate vancomycin dosing is associated with treatment failures and the emergence of heteroresistant MRSA.
Conclusions:
- Aggressive vancomycin dosing requires careful consideration due to increased nephrotoxicity risk, especially in vulnerable patients.
- Clinicians should adhere to established guidelines for vancomycin dosing to optimize treatment efficacy and minimize renal adverse events.
- Alternative antibiotics should be considered for patients where guideline-adherent vancomycin dosing is not feasible or desired due to potential risks.
Related Concept Videos
Drug Toxicity: Risk factors
Drug Toxicity: Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Allergic Reactions
